相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Pharmacokinetics of Oral Sitamaquine Taken with or without Food and Safety and Efficacy for Treatment of Visceral Leishmaniais: A Randomized Study in Bihar, India
Shyam Sundar et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis
Leandro Ourives Neves et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2011)
Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis
V. Ramesh et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Liposomal Amphotericin B for Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients: 2-Year Treatment Outcomes in Bihar, India
Prabhat K. Sinha et al.
CLINICAL INFECTIOUS DISEASES (2011)
Limited Effectiveness of High-Dose Liposomal Amphotericin B (AmBisome) for Treatment of Visceral Leishmaniasis in an Ethiopian Population With High HIV Prevalence
Koert Ritmeijer et al.
CLINICAL INFECTIOUS DISEASES (2011)
Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica
M. Solomon et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
Shyam Sundar et al.
LANCET (2011)
Single-dose liposomal amphotericin B (AmBisome®) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial
Tansy Edwards et al.
TRIALS (2011)
Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial
Raymond Omollo et al.
TRIALS (2011)
A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries
Suerie Moon et al.
GLOBALIZATION AND HEALTH (2011)
Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India
Prabhat K. Sinha et al.
JOURNAL OF TROPICAL MEDICINE (2011)
Lipsosomal Amphotericin B for Treatment of Cutaneous Leishmaniasis
Glenn Wortmann et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Randomized Controlled Trial of Local Heat Therapy Versus Intravenous Sodium Stibogluconate for the Treatment of Cutaneous Leishmania major Infection
Naomi E. Aronson et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study
Ahmed M. Musa et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial
Asrat Hailu et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial
Paulo R. Machado et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Parasite Susceptibility to Amphotericin B in Failures of Treatment for Visceral Leishmaniasis in Patients Coinfected with HIV Type 1 and Leishmania infantum
Laurence Lachaud et al.
CLINICAL INFECTIOUS DISEASES (2009)
Is Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A Meta-Analysis of 14 Randomized Controlled Trials
Dae Hyun Kim et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony
Cesar Miranda-Verastegui et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
New treatment approach in Indian visceral leishmaniasis: Single-dose liposomal amphotericin B followed by short-course oral miltefosine
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2008)
The relationship between leishmaniasis and AIDS: the second 10 years
Jorge Alvar et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal - the challenges for diagnosis and treatment
Shyam Sundar et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
I. Molina et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis
Sujit Kumar Bhattacharya et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Injectable paromomycin for visceral leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis
Iracema Arevalo et al.
CLINICAL INFECTIOUS DISEASES (2007)
Oral pentoxifylline combined with pentavalent antimony: A randomized trial for mucosal leishmaniasis
Paulo R. L. Machado et al.
CLINICAL INFECTIOUS DISEASES (2007)
Treatment of Bolivian mucosal leishmaniasis with miltefosine
J. Soto et al.
CLINICAL INFECTIOUS DISEASES (2007)
Cutaneous leishmaniasis
Richard Reithinger et al.
LANCET INFECTIOUS DISEASES (2007)
Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis
Michal Solomon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Liposomal amphotericin B for the treatment of visceral leishmaniasis
Caryn Bern et al.
CLINICAL INFECTIOUS DISEASES (2006)
A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection
K Ritmeijer et al.
CLINICAL INFECTIOUS DISEASES (2006)
Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis
G. Sadeghian et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)
Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana
M. Roussel et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2006)
In vitro and in vivo interactions between miltefosine and other antileishmanial drugs
K Seifert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Treatment of visceral leishmaniasis
S Sundar et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan:: A randomized, controlled trial
R Reithinger et al.
CLINICAL INFECTIOUS DISEASES (2005)
A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis
M Nassiri-Kashani et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2005)
Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime®) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime®) alone for the treatment of cutaneous leishmaniasis
A Asilian et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2004)
Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases
M Montana et al.
PATHOLOGIE BIOLOGIE (2004)
Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
R López-Vélez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Miltefosine for New World cutaneous leishmaniasis
J Soto et al.
CLINICAL INFECTIOUS DISEASES (2004)
Leishmania/HIV co-infections:: epidemiology in Europe
P Desjeux et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2003)
The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis
A Asilian et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2003)
Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
S Rijal et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2003)
Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis
V Syriopoulou et al.
CLINICAL INFECTIOUS DISEASES (2003)
Post-kala-azar dermal leishmaniasis
EE Zijistra et al.
LANCET INFECTIOUS DISEASES (2003)
Oral miltefosine for Indian visceral leishmaniasis
S Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major
AA Alrajhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator
I Arevalo et al.
CLINICAL INFECTIOUS DISEASES (2001)
分享论文
